JP MORGAN/PUT/BOSTON SCIENTIFIC/50/0.1/17.01.25 Share Price

Warrant

DE000JL03GU2

Market Closed - Börse Stuttgart 12:44:40 14/06/2024 pm IST
0.099 EUR +6.45% Intraday chart for JP MORGAN/PUT/BOSTON SCIENTIFIC/50/0.1/17.01.25
Current month-10.00%
1 month-23.85%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
14/24/14 0.099 +6.45%
13/24/13 0.093 +9.41%
12/24/12 0.085 -1.16%
11/24/11 0.086 -3.37%
10/24/10 0.089 -4.30%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:44 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer J.P. Morgan
WKN JL03GU
ISINDE000JL03GU2
Date issued 05/04/2023
Strike 50 $
Maturity 17/01/2025 (215 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.81
Lowest since issue 0.085
Delta-0.09x
Omega 4.640
Premium36.72x
Gearing53.91x
Moneyness 0.6514
Difference Strike -26.76 $
Difference Strike %-53.52%
Spread 0.074
Spread %43.53%
Theoretical value 0.1330
Implied Volatility 51.26 %
Total Loss Probability 83.41 %
Intrinsic value 0.000000
Present value 0.1330
Break even 48.58 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
76.76 USD
Average target price
82.26 USD
Spread / Average Target
+7.16%
Consensus